GeneDx Reports Q1 2025 Earnings Results
GeneDx (WGS) reported Q1 2025 earnings with total revenue of $87.1 million, driven by a 62% growth in exome and genome revenues. The company also raised its full-year revenue guidance to $360 million to $375 million, reflecting strong performance and improved reimbursement rates.
Tickers: $WGS
Topics: acquisition earnings financial performance genomics revenue growth